What the company does
Huons makes prescription medicines, including local anaesthetics and eye drops, as well as wellness injectables such as vitamin drips and weight-management drugs.
It supplies hospitals, clinics, and pharmacies across South Korea, and also manufactures medicines on a contract basis for other domestic and international pharmaceutical companies. Listed on KOSDAQ, South Korea's tech and small-cap exchange, the company operates across three distinct segments: prescription pharmaceuticals, beauty and wellness products, and contract manufacturing.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue · FY2025
US$449.8M
▲ +5.2% YoY
Operating profit · FY2025
US$33M
▲ +14.9% YoY
Net income · FY2025
US$30.6M
▲ +45.3% YoY
Revenue
- FY2023US$400M
- FY2024US$427.7M
- FY2025US$449.8M
Operating profit
- FY2023US$40.6M
- FY2024US$28.8M
- FY2025US$33M
Net income
- FY2023US$36.5M
- FY2024US$21.1M
- FY2025US$30.6M
Key ratios (FY2025)
ROE
10.2%
Debt/Eq
164.0%
Op. margin
7.3%
Net margin
6.8%
Rev. YoY
▲ +5.2%
Price charts coming soon
Interactive price history isn't here yet. Would you use it?